艾昆纬（IQVIA）：2026年演讲局（Speaker Bureau）基准报告（英文版）（24页）.pdf

1、2026 Speaker BureauBenchmarks Report CLARA GOMES,Assoc.Director,Operational Effectiveness,Speaker Bureau,IQVIATIFFANY GALLO,Director,Customer Success,Speaker Bureau,IQVIAHEATHER MURRAY,Director,Customer Success,Speaker Bureau,IQVIAJAMES CONSOLE,Director,Strategic Operations,Speaker Bureau,IQVIATable

2、 of contentsIntroduction 1Evaluation methodology 1Therapeutic area reclassification 2Live programs continued strength 3Live programs edge continued 4Costs increased for most program types 8Speaker fees varied across therapeutic areas 10Conclusion 12Appendix 13Cardiovascular/Metabolic 13Infectious di

3、sease/immunology 14Neurology/psychiatry 16Oncology 18Respiratory 19About the authors 21 |1IntroductionThe 2026 Speaker Bureau Benchmarks Report provides an updated view of program performance across IQVIAs portfolio,highlighting trends in mix,attendance,costs,and therapeutic-area dynamics based on c

4、ompleted 2025 program activity.While overall engagement volume declined modestly,the structure of the channel remains stable.Live formats continued to anchor engagement across therapeutic areas,and Virtual programs maintained their role as scalable formats that expand reach.Performance across therap

5、eutic areas reflects a maturing and an increasingly predictable environment.Most therapeutic areas clearly exhibit expected launch and post-launch patterns.At the same time,rapidly expanding areas such as neurology and respiratory continued to grow,contributing meaningfully to demand and engagement.

6、Cost patterns varied by format,with inflationary pressure raising Live program costs,while increasing operational efficiencies drove down Virtual Link programs costs.A review of the data by therapeutic area shows that neurology and respiratory had notable increases in program volume.In contrast,card